129 related articles for article (PubMed ID: 21108965)
1. Construction of a highly-active, liver-specific transcriptional regulatory element through combination of the albumin promoter and α-fetoprotein enhancer.
Chen EQ; Song XQ; Wang YL; Zhou TY; Bai L; Liu L; Liu C; Cheng X; Tang H
Plasmid; 2011 Mar; 65(2):125-31. PubMed ID: 21108965
[TBL] [Abstract][Full Text] [Related]
2. Construction of a plasmid vector for liver-specific inhibition of hepatocyte nuclear factor 4 alpha expression.
Song XQ; Chen EQ; Wang YB; Zhou TY; Liu L; Liu C; Cheng X; Tang H
Plasmid; 2012 Jan; 67(1):60-6. PubMed ID: 21907733
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
Ido A; Uto H; Moriuchi A; Nagata K; Onaga Y; Onaga M; Hori T; Hirono S; Hayashi K; Tamaoki T; Tsubouchi H
Cancer Res; 2001 Apr; 61(7):3016-21. PubMed ID: 11306481
[TBL] [Abstract][Full Text] [Related]
4. Functional mapping of tissue-specific elements of the human alpha-fetoprotein gene enhancer.
Nakabayashi H; Koyama Y; Suzuki H; Li HM; Sakai M; Miura Y; Wong NC; Nishi S
Biochem Biophys Res Commun; 2004 Jun; 318(3):773-85. PubMed ID: 15144905
[TBL] [Abstract][Full Text] [Related]
5. The function of 3' noncoding sequences of hepatitis B surface antigen gene in a non-hepatic cell expression system.
Liu D; Shen X; Tian K
Chin J Biotechnol; 1993; 9(4):235-40. PubMed ID: 8061232
[TBL] [Abstract][Full Text] [Related]
6. The effect of HSV-tk/GCV on hepatic specific damage driven by murine ALB promoter/enhancer.
Zhang Y; Huang SZ; Zeng YT
Yi Chuan Xue Bao; 2004 Oct; 31(10):1053-60. PubMed ID: 15552038
[TBL] [Abstract][Full Text] [Related]
7. [Construction of pGL3-SM22-SCAP (D443N) eukaryotic expression vector and its expression in CHO cells].
Wang Y; Hu J; Cui J; Huang A; Ruan X; Chen Y
Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):114-20. PubMed ID: 20353101
[TBL] [Abstract][Full Text] [Related]
8. Prostate stem cell antigen enhancer and uroplakin II promoter based bladder cancer targeted tissue-specific vector.
Wang D; Wang Z; Tian J; He X; Chowdhury WH; Zhang X; Li S; Rodriguez R
Urol Oncol; 2010; 28(2):164-9. PubMed ID: 18440837
[TBL] [Abstract][Full Text] [Related]
9. Functional analyses of albumin expression in a series of hepatocyte cell lines and in primary hepatocytes.
Hu JM; Camper SA; Tilghman SM; Miller T; Georgoff I; Serra R; Isom HC
Cell Growth Differ; 1992 Sep; 3(9):577-88. PubMed ID: 1419909
[TBL] [Abstract][Full Text] [Related]
10. [Construction of eukaryotic expression vector expressing hepatitis B virus HBsAg and EGFP fusion protein and establishment of stable transfected Chang Liver cell line].
Mu JS; Wang HF; Wang JH; Pan XB; Zhang L; Wei L
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):228-30. PubMed ID: 19031712
[TBL] [Abstract][Full Text] [Related]
11. [Inhibition of HBV DNA replication and expression in 2.2.15 hepatoma cells infected with AFP-mediated HBX antisense RNA].
Ma CH; Sun WS; Liu SX; Wang XY; Zhang LN; Cao YL; Han LH
Zhonghua Gan Zang Bing Za Zhi; 2003 May; 11(5):291-4. PubMed ID: 12773245
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the human C6 promoter: requirement of the CCAAT enhancer binding protein binding site for C6 gene promoter activity.
González S; López-Larrea C
J Immunol; 1996 Sep; 157(6):2282-90. PubMed ID: 8805625
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte-specific gene expression from integrated lentiviral vectors.
Nash KL; Jamil B; Maguire AJ; Alexander GJ; Lever AM
J Gene Med; 2004 Sep; 6(9):974-83. PubMed ID: 15352070
[TBL] [Abstract][Full Text] [Related]
14. Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.
Mawatari F; Tsuruta S; Ido A; Ueki T; Nakao K; Kato Y; Tamaoki T; Ishii N; Nakata K
Cancer Gene Ther; 1998; 5(5):301-6. PubMed ID: 9824049
[TBL] [Abstract][Full Text] [Related]
15. Short and highly efficient synthetic promoters for melanoma-specific gene expression.
Martinelli R; De Simone V
FEBS Lett; 2005 Jan; 579(1):153-6. PubMed ID: 15620705
[TBL] [Abstract][Full Text] [Related]
16. A hypoxia-inducible gene expression system using erythropoietin 3' untranslated region for the gene therapy of rat spinal cord injury.
Choi BH; Ha Y; Ahn CH; Huang X; Kim JM; Park SR; Park H; Park HC; Kim SW; Lee M
Neurosci Lett; 2007 Jan; 412(2):118-22. PubMed ID: 17178192
[TBL] [Abstract][Full Text] [Related]
17. Hepatoma cell-specific expression of a retrovirally transferred gene is achieved by alpha-fetoprotein but not insulinlike growth factor II regulatory sequences.
Arbuthnot P; Bralet MP; Thomassin H; Danan JL; Bréchot C; Ferry N
Hepatology; 1995 Dec; 22(6):1788-96. PubMed ID: 7489990
[TBL] [Abstract][Full Text] [Related]
18. [Construction of a hepatoma-targeting vector of adeno-associated virus containing human alpha-fetoprotein promoter and wild p53 gene in gene therapy of liver cancer].
Cheng J; Leng X; Peng J
Zhonghua Yi Xue Za Zhi; 2000 Jun; 80(6):461-3. PubMed ID: 11798803
[TBL] [Abstract][Full Text] [Related]
19. Development of artificial chimerical gene regulatory elements specific for cancer gene therapy.
Shin JH; Yi JK; Lee YJ; Kim AL; Park MA; Kim SH; Lee H; Kim CG
Oncol Rep; 2003; 10(6):2063-9. PubMed ID: 14534744
[TBL] [Abstract][Full Text] [Related]
20. CREB/PKA sensitive signalling pathways activate and maintain expression levels of the hepatitis B virus pre-S2/S promoter.
Tacke F; Liedtke C; Bocklage S; Manns MP; Trautwein C
Gut; 2005 Sep; 54(9):1309-17. PubMed ID: 15871998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
